Central Monitoring Summit

Conference themes
Successfully introducing new drugs and therapies in a quicker and more cost-effective manner starts in the most complex phase on of drug development; the clinical phase. The implementation of risk-based monitoring increases the overall quality of data while providing better oversight of patient safety. With the introduction of centralized monitoring in a risk-based monitoring approach, pharmaceutical companies are able to embrace a real-time overview of data and risk detection.

Professional congress organizer (PCO)
ExL Events

https://go.evvnt.com/177774-1?pid=4832

Ms. Camille Venturina